Access to European Union law
<a href="https://eur-lex.europa.eu/content/help/eurlex-content/experimental-features.html" target="_blank">More about the experimental features corner</a>
Choose the experimental features you want to try
EUR-Lex
Access to European Union law

This document is an excerpt from the EUR-Lex website

You are here
Use quotation marks to search for an "exact phrase". Append an asterisk (*) to a search term to find variations of it (transp*, 32019R*). Use a question mark (?) instead of a single character in your search term to find variations of it (ca?e finds case, cane, care).
Search tips
Need more search options? Use the Advanced search

Document 31994R2701

    Commission Regulation (EC) No 2701/94 of 7 November 1994 amending Annexes I, II, III and IV to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin (Text with EEA relevance)

    IO L 287, 8.11.1994, p. 7–17 (ES, DA, DE, EL, EN, FR, IT, NL, PT)

    ⏵Foilsíodh an doiciméad seo in eagrán speisialta (FI, SV, CS, ET, LV, LT, HU, MT, PL, SK, SL, BG, RO)

    Legal status of the document No longer in force, Date of end of validity: 05/07/2009; Arna aisghairm go hintuigthe ag 32009R0470

    ELI: http://data.europa.eu/eli/reg/1994/2701/oj

    8.11.1994   

    EN

    Official Journal of the European Communities

    L 287/7

    COMMISSION REGULATION (EC) NO 2701/94

    of 7 November 1994

    amending Annexes I, II, III and IV to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin

    (Text with EEA relevance)

    THE COMMISSION OF THE EUROPEAN COMMUNITIES,

    Having regard to the Treaty establishing the European Community,

    Having regard to Council Regulation (EEC) No 2377/90 of 26 June 1990 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin (1), as last amended by Commission Regulation (EC) No 1430/94 (2), and in particular Articles 6, 7 and 8 thereof,

    Whereas, since the adoption of the Regulation, the Annexes have been amended a number of times; whereas, by reason of their number, their complexity and their dispersal among various Official Journals of the European Communities, the texts are difficult to use and thus lack the clarity which should be an essential feature of all legislation; whereas, they should therefore be consolidated; whereas on the same occasion the name or chemical description of some compounds should be rectified or made more precise and certain material errors should be corrected;

    Whereas the measures provided for in this Regulation are in accordance with the opinion of the Committee for the adaptation to technical progress of directives on the removal of technical barriers to trade in the veterinary medicinal products sector,

    HAS ADOPTED THIS REGULATION:

    Article 1

    Annexes I, II, III and IV to Regulation (EEC) No 2377/90 are hereby amended as set out in the Annex hereto.

    Article 2

    This Regulation shall enter into force on the 60th day following its publication in the Official Journal of the European Communities.

    This Regulation shall be binding in its entirety and directly applicable in all Member States.

    Done at Brussels, 7 November 1994.

    For the Commission

    Martin BANGEMANN

    Member of the Commission

    (1)  OJ No L 224, 18. 8. 1990, p. 1.

    (2)  OJ No L 156, 23. 6. 1994, p. 6.

    ANNEX

    ‘

    ANNEX I

    List of pharmacologically active substances for which maximum residue limits have been fixed

    1.

    Anti-infectious agents

    1.1.

    Chemotherapeutics

    1.1.1.

    Sulfonamides

    Pharmacologically active substance(s)

    Marker residue

    Animal species

    MRLs

    Target tissues

    Other provisions

    All substances belonging to the sulfonamide group

    Parent drug

    All food producing species

    100 μg/kg

    Muscle, liver, kidney, fat

    The combined total residues of all substances within the sulfonamide group should not exceed 100 μg/kg

    1.2.

    Antibiotics

    1.2.1.

    Penicillins

    Pharmacologically active substance(s)

    Marker residue

    Animal species

    MRLs

    Target tissues

    Other provisions

    1.2.1.1.

    Benzylpenicillin

    Benzylpenicillin

    All food producing species

    50 μg/kg

    Muscle, liver, kidney, fat

     

    4 μg/kg

    Milk

     

    1.2.1.2.

    Ampicillin

    Ampicillin

    All food producing species

    50 μg/kg

    Muscle, liver, kidney, fat

     

    4 μg/kg

    Milk

     

    1.2.1.3.

    Amoxicillin

    Amoxicillin

    All food producing species

    50 μg/kg

    Muscle, liver, kidney, fat

     

    4 μg/kg

    Milk

     

    1.2.1.4.

    Oxacillin

    Oxacillin

    All food producing species

    300 μg/kg

    Muscle, liver, kidney, fat

     

    30 μg/kg

    Milk

     

    1.2.1.5.

    Cloxacillin

    Cloxacillin

    All food producing species

    300 μg/kg

    Muscle, liver, kidney, fat

     

    30 μg/kg

    Milk

     

    1.2.1.6.

    Dicloxacillin

    Dicloxacillin

    All food producing species

    300 μg/kg

    Muscle, liver, kidney, fat

     

    30 μg/kg

    Milk

     

    1.2.2.

    Cephalosporins

    Pharmacologically active substance(s)

    Marker residue

    Animal species

    MRLs

    Target tissues

    Other provisions

    1.2.2.1.

    Cefquinome

    Cefquinome

    Bovine

    200 μg/kg

    Kidney

     

    100 μg/kg

    Liver

     

    50 μg/kg

    Muscle

     

    50 μg/kg

    Fat

     

    1.2.3.

    Quinolones

    Pharmacologically active substance(s)

    Marker residue

    Animal species

    MRLs

    Target tissues

    Other provisions

    1.2.3.1.

    Enrofloxacin

    Sum of enrofloxacin and ciprofloxacin

    Bovine, porcine, poultry

    30 μg/kg

    Muscle, liver, kidney

     

    1.2.4.

    Macrolides

    Pharmacologically active substance(s)

    Marker residue

    Animal species

    MRLs

    Target tissues

    Other provisions

    1.2.4.1. Tilmicosin

    Tilmicosin

    Bovine

    1 000 μg/kg

    Liver, kidney

     

    50 μg/kg

    Muscle, fat

     

    2.

    Antiparasitic agents

    2.1.

    Agents acting against endoparasites

    2.1.1.

    Avermectins

    Pharmacologically active substance(s)

    Marker residue

    Animal species

    MRLs

    Target tissues

    Other provisions

    2.1.1.1.

    Ivermectin

    22,23- Dihydroavermectin B1a

    Bovine

    100 μg/kg

    Liver

     

    40 μg/kg

    Fat

     

    Porcine

    15 μg/kg

    Liver

     

    Ovine

    20 μg/kg

    Fat

     

    Equidae

    2.1.1.2.

    Abamectin

    Avermectin B1a

    Bovine

    20 μg/kg

    Liver

     

    10 μg/kg

    Fat

     

    2.1.1.3.

    Doramectin

    Doramectin

    Bovine

    15 μg/kg

    Liver

     

    25 μg/kg

    Fat

     

    2.1.2

    Salicylanilides

    Pharmacologically active substance(s)

    Marker residue

    Animal species

    MRLs

    Target tissues

    Other provisions

    2.1.2.1.

    Closantel

    Closantel

    Bovine

    1 000 μg/kg

    Muscle, liver

     

    3 000 μg/kg

    Kidney, fat

     

    Ovine

    1 500 μg/kg

    Muscle, liver

     

    5 000 μg/kg

    Kidney, fat

     

    2 000 μg/kg

     

     

    ANNEX II

    List of substances not subject to maximum residue limits

    1.

    Inorganic chemicals

    Pharmacologically active substance(s)

    Animal species

    Other provisions

    1.1.

    Hydrogen peroxide

    Fish

     

    1.2.

    Sulphur

    Bovine

     

    Porcine

     

    Ovine

     

    Caprine

     

    Equidae

     

    1.3.

    Iodine and iodine inorganic compounds including:

    —

    Sodium and potassium — iodide

    —

    Sodium and potassium — iodate

    —

    Iodophors including polyvinylpyrrolidone — iodine

    All food producing species

     

    1.4.

    Sodium chlorite

    Bovine

    For tropical use only

    2.

    Organic compounds

    Pharmacologically active substance(s)

    Animal species

    Others provisions

    2.1.

    Etiproston tromethamine

    Bovine

     

    Porcine

     

    2.2.

    Ketanserin tartrate

    Equidae

     

    2.3.

    Fertirelin acetate

    Bovine

     

    2.4.

    Human menopausal urinary gonadotrophin

    Bovine

     

    2.5.

    Lactic acid

    All food producing species

     

    2.6.

    Melatonin

    Ovine

     

    Caprine

     

    2.7.

    Iodine organic compounds

    —

    Iodoform

    All food producing species

     

    2.8.

    Acetyl cysteine

    All food producing species

     

    ANNEX III

    List of pharmacologically active substances used in veterinary medicinal products for which provisional maximum residue limits have been fixed

    1.

    Anti-infectious agents

    1.1.

    Chemotherapeutics

    1.1.1.

    Sulfonamides

    Pharmacologically active substance(s)

    Marker residue

    Animal species

    MRLs

    Target tissues

    Other provisions

    All substances belonging to the sulfonamide group

    Parent drug

    Bovine, ovine, caprine

    100 μg/kg

    Milk

    Provisional MRL expires on 1. 1. 1996. The combined total residues of all substances within the sulfonamide group should not exceed 100 μg/kg

    1.1.2.

    Diamino pyrimidine derivates

    Pharmacologically active substance(s)

    Marker residue

    Animal species

    MRLs

    Target tissues

    Other provisions

    1.1.2.1.

    Trimethoprim

    Trimethoprim

    All food producing species

    50 μg/kg

    Muscle, liver, kidney, fat, milk

    Provisional MRL expires on 1. 1. 1996

    1.1.3.

    Nitrofurans

    Pharmacologically active substance(s)

    Marker residue

    Animal species

    MRLs

    Target tissues

    Other provisions

    1.1.3.1.

    Furazolidone

    All residues with intact 5-nitro structure

    All food producing species

    5 μg/kg

    Muscle, liver, kidney, fat

    Provisional MRL expires on 1. 7. 1995

    1.1.4.

    Nitroimidazoles

    Pharmacologically active substance(s)

    Marker residue

    Animal species

    MRLs

    Target tissues

    Other provisions

    1.1.4.1.

    Dimetridazole

    All residues with intact nitroimidazole structure

    All food producing species

    10 μg/kg

    Muscle, liver, kidney, fat

    Provisional MRL expires on 1. 1. 1995

    1.2.

    Antibiotics

    1.2.1.

    Tetracyclines

    Pharmacologically active substance(s)

    Marker residue

    Animal species

    MRLs

    Target tissues

    Other provisions

    All substances belonging to the tetracycline group

    Parent drug

    All food producing species

    600 μg/kg

    Kidney

    Provisional MRLs expire on 1. 1. 1996. The combined total residues of all substances within the tetracycline group should not exceed the limits indicated

    300 μg/kg

    Liver

    200 μg/kg

    Eggs

    100 μg/kg

    Muscle

    100 μg/kg

    Milk

    1.2.2.

    Macrolides

    Pharmacologically active substance(s)

    Marker residue

    Animal species

    MRLs

    Target tissues

    Other provisions

    1.2.2.1.

    Spiramycin

    Spiramycin

    Bovine, porcine

    300 μg/kg

    Liver,

    Provisional MRLs expire on 1. 7. 1995. The MRLs for liver, kidney and muscle apply to both the bovine and porcine species

    200 μg/kg

    Kidney,

    50 μg/kg

    Muscle

    Bovine

    150 μg/kg

    Milk

    1.2.2.2.

    Tylosin

    Bovine

    100 μg/kg

    Muscle, liver, kidney

    Provisional MRLs expire on 1. 7. 1995

    Porcine

     

     

    Poultry

     

     

    Bovine

    50 μg/kg

    Milk

    1.2.3.

    Thiamphenicol and related compounds

    Pharmacologically active substance(s)

    Market residue

    Animal species

    MRLs

    Target tissues

    Other provisions

    1.2.3.1.

    Thiamphenicol

    Thiamphenicol

    Bovine

    Poultry

    40 μg/kg

    Muscle, liver, kidney, fat

    Provisional MRL expires on 1. 1. 1996

    2.

    Antiparasitic agents

    2.1.

    Agents acting against endo-parasites

    2.1.1.

    Benzimidazoles and pro-benzimidazoles

    Pharmacologically active substance(s)

    Marker residue

    Animal species

    MRLs

    Target tissues

    Other provisions

    2.1.1.1.

    Febantel

    Combined residues of oxfendazole, oxfendazole sulfone and fenbendazole

    All food producing species

    1 000 μg/kg

    Liver

    Provisional MRLs expire on 1. 7. 1995. The MRLs cover all residues of febantel, fenbendazole and oxfendazole

    10 μg/kg

    Muscle, kidney, fat

    10 μg/kg

    Milk

    2.1.1.2.

    Fenbendazole

    Combined residues of oxfendazole, oxfendazole sulfone and fenbendazole

    All food producing species

    1 000 μg/kg

    Liver

    Provisional MRLs expire on 1. 7. 1995. The MRLs cover all residues of febantel, fenbendazole and oxfendazole

    10 μg/kg

    Muscle, kidney, fat

    10 μg/kg

    Milk

    2.1.1.3.

    Oxfendazole

    Combined residues of oxfendazole, oxfendazole sulfone and fenbendazole

    All food producing species

    1 000 μg/kg

    Liver

    Provisional MRLs expire on 1. 7. 1995. The MRLs cover all residues of febantel, fenbendazole and oxfendazole

    10 μg/kg

    Muscle, kidney, fat

    10 μg/kg

    Milk

    2.1.1.4.

    Albendazole

    Sum of albendazole and metabolites which are measured as 2-amino-benzimidazole sulphone

    Bovine

    100 μg/kg

    Muscle, fat, milk,

    Provisional MRLs expire on 1. 1. 1996

    Ovine

    500 μg/kg

    Kidney

     

    1 000 μg/kg

    Liver

    2.1.1.5.

    Thiabendazole

    Sum of thiabendazole and 5-hydroxythiabendazole

    Bovine

    100 μg/kg

    Muscle, liver, kidney, fat, milk

    Provisional MRLs expire on 1. 1. 1996

    Ovine

     

    Caprine

     

    2.1.1.6.

    Triclabendazole

    Sum of extractable residues that may be oxidized to ketotriclabendazole

    Bovine

    150 μg/kg

    Muscle, liver, kidney

    Provisional MRLs expire on 1. 7. 1995

    Ovine

    50 μg/kg

    Fat

    2.1.1.7.

    Flubendazole

    Flubendazole

    Poultry

    500 μg/kg

    Liver,

    Provisional MRLs expire on 1. 1. 1996

    Game birds

    200 μg/kg

    Muscle,

    400 μg/kg

    Eggs

    Porcine

    10 μg/kg

    Muscle, liver, kidney, fat

    2.1.1.8.

    Oxibendazole

    Oxibendazole

    Bovine

    Ovine

    100 μg/kg

    Muscle, liver, kidney, fat

    Provisional MRLs expire on 1. 1. 1996

     

    50 μg/kg

    Milk

    Porcine

    Equidae

    100 μg/kg

    Muscle, liver, kidney, fat

    2.1.2.

    Tetra-hydro-imidazoles (imidazolthiazoles)

    Pharmacologically active substance(s)

    Marker residue

    Animal species

    MRLs

    Target tissues

    Other provisions

    2.1.2.1.

    Levamisole

    Levamisole

    All food producing species

    10 μg/kg

    Musle, liver, kidney, fat, milk

    Provisional MRL expires on 1. 1. 1995

    2.2.

    Agents acting against ectoparasites

    Pharmacologically active substance(s)

    Marker residue

    Animal species

    MRLs

    Target tissues

    Other provisions

    2.2.1.

    Amitraz

    Sum of amitraz and metabolites which are measured as 2,4-dimethylaniline

    Porcine

    50 μg/kg

    Muscle

    Provisional MRLs expire on 1. 7. 1996.

    200 μg/kg

    Kidney, liver

    3.

    Agents acting on the nervous system

    3.1.

    Agents acting on the central nervous system

    3.1.1.

    Butyrophenone tranquilizers

    Pharmacologically active substance(s)

    Marker residue

    Animal species

    MRLs

    Target tissues

    Other provisions

    3.1.1.1.

    Azaperone

    Azaperol

    All food producing species

    100 μg/kg

    Kidney

    Provisional MRLs expire on 1. 1. 1996

    50 μg/kg1

    Liver, muscle, fat

    3.2.

    Agents acting on the autonomic nervous system

    3.2.1.

    Anti-adrenergics

    Pharmacologically active substance(s)

    Marker residue

    Animal species

    MRLs

    Target tissues

    Other provisions

    3.2.1.1.

    Carazolol

    Carazolol

    All food producing species

    30 μg/kg

    Liver

    Provisional MRLs expire on 1. 7. 1995

    5 μg/kg

    Kidney, muscle, fat

    ANNEX IV

    List of pharmacologically active substances for which no maximum levels can be fixed

    1.

    Nitrofurans, except furazolidone (see Annex III)

    2.

    Ronidazole

    3.

    Dapsone

    4.

    Chloramphenicol
    ’
    Top